Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

28.06
-1.4800-5.01%
Post-market: 28.130.0700+0.25%19:56 EDT
Volume:15.06M
Turnover:423.52M
Market Cap:6.55B
PE:-45.04
High:29.62
Open:29.20
Low:27.49
Close:29.54
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:213.68M
Volume Ratio:1.87
T/O Rate:7.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:20.20
PE(LYR):54.77

Loading ...

Hims & Hers's Peptide Opportunity Remains in Focus

Dow Jones
·
Jul 10

Hims & Hers Health is Maintained at Neutral by B of a Securities

Dow Jones
·
Jul 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Jul 09

Movement Alert|Hims & Hers Health Falls 5.11% in Regular Trading, Trading at $34.26

Market Focus
·
Jul 08

Movement Alert|Hims & Hers Health Falls 5.2% in Pre-Market Trading, Trading at $34.45

Market Focus
·
Jul 08

Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56

Reuters
·
Jul 08

Movement Alert|Hims & Hers Health Declines 5.02% in Regular Trading, Trading at $36.33

Market Focus
·
Jul 08

Movement Alert|Hims & Hers Health Rises 5.14% in Regular Trading, Continued Momentum Following BofA Price Target Upgrade

Market Focus
·
Jul 06

Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Dow Jones
·
Jul 05

Hims & Hers Health (HIMS) Secures $400 Million Financing, Is The Upside Already Priced In?

Simply Wall St.
·
Jul 02

Hims & Hers Health - Receivables Purchase Agreement Has Initial 364-day Term, Extendable by Written Agreement - SEC Filing

THOMSON REUTERS
·
Jul 02

Hims & Hers Signs USD 400 Million Receivables Purchase Facility with Jpmorgan Chase

Reuters
·
Jul 02

Sector Update: Healthcare

MT Newswires Live
·
Jul 02

Movement Alert|Hims & Hers Health Rises 5.12% in Regular Trading, BofA Securities Raises Price Target to $36 From $25

Market Focus
·
Jul 01

BofA Securities Adjusts Hims & Hers Health Price Target to $36 From $25, Maintains Neutral Rating

MT Newswires Live
·
Jul 01

Hims & Hers Health is Maintained at Neutral by B of a Securities

Dow Jones
·
Jul 01

HIMS Stock Jumps after Canaccord Raises Price Target to Street-High of $40

TIPRANKS
·
Jul 01

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Oruka Therapeutics (ORKA) and Hims & Hers Health (HIMS)

TIPRANKS
·
Jul 01

Hims & Hers : Bofa Global Research Raises Price Objective to $36.00 from $25.00

THOMSON REUTERS
·
Jul 01

Moderately bullish activity in Hims and Hers Health with shares up 5.3%

TIPRANKS
·
Jun 26